Seaport Therapeutics, Inc. (SPTX)
NASDAQ: SPTX · Real-Time Price · USD
24.88
+1.27 (5.38%)
At close: Sep 2, 2026, 4:00 PM EDT
24.91
+0.03 (0.12%)
After-hours: Sep 2, 2026, 4:10 PM EDT
Seaport Therapeutics Earnings Call Transcripts
Fiscal Year 2026
-
The company presented its neuropsychiatry-focused pipeline, highlighting the Glyph platform's ability to improve oral bioavailability and safety of known drugs. Key milestones include phase II-B and driving study data for GlyphAllo in 2026–2027 and phase II studies for GlyphAgo in 2028, with funding secured into 2029.